A Multi-Institutional Study to Evaluate Automated Whole Slide Scoring of Immunohistochemistry for Assessment of Programmed Death-Ligand 1 (PD-L1) Expression in Non-Small Cell Lung Cancer
- PMID: 30640753
- DOI: 10.1097/PAI.0000000000000737
A Multi-Institutional Study to Evaluate Automated Whole Slide Scoring of Immunohistochemistry for Assessment of Programmed Death-Ligand 1 (PD-L1) Expression in Non-Small Cell Lung Cancer
Abstract
Assessment of programmed death-ligand 1 (PD-L1) expression is a critical part of patient management for immunotherapy. However, studies have shown that pathologist-based analysis lacks reproducibility, especially for immune cell expression. The purpose of this study was to validate reproducibility of the automated machine-based Optra image analysis for PD-L1 immunohistochemistry for both tumor cells (TCs) and immune cells. We compared conventional pathologists' scores for both tumor and immune cell positivity separately using 22c3 antibody on the Dako Link 48 platform for PD-L1 expression in non-small cell lung carcinoma. We assessed interpretation first by pathologists and second by PD-L1 image analysis scores. Lin's concordance correlation coefficients (LCCs) for each pathologist were measured to assess variability between pathologists and between pathologists and Optra automated quantitative scores in scoring both tumor and immune cells. Lin's LCCs to evaluate the correlation between pathologists for TC was 0.75 [95% confidence interval (CI), 0.64-0.81] and 0.40 (95% CI, 0.40-0.62) for immune cell scoring. Pathologists were highly concordant for tumor scoring, but not for immune cell scoring, which is similar to previously reported studies where agreement is higher in TCs than immune cells. The LCCs between conventional pathologists' read and the machine score were 0.80 (95% CI, 0.74-0.85) for TCs and 0.70 (95% CI, 0.60-0.76) for immune cell population. This is considered excellent agreement for TCs and good concordance for immune cells. The automated scoring methods showed concordance with the pathologists' average scores that were comparable to interpathologist scores. This suggests promise for Optra automated assessment of PD-L1 in non-small cell lung cancer.
Similar articles
-
A Prospective, Multi-institutional, Pathologist-Based Assessment of 4 Immunohistochemistry Assays for PD-L1 Expression in Non-Small Cell Lung Cancer.JAMA Oncol. 2017 Aug 1;3(8):1051-1058. doi: 10.1001/jamaoncol.2017.0013. JAMA Oncol. 2017. PMID: 28278348 Free PMC article.
-
Comparison of continuous measures across diagnostic PD-L1 assays in non-small cell lung cancer using automated image analysis.Mod Pathol. 2020 Mar;33(3):380-390. doi: 10.1038/s41379-019-0349-y. Epub 2019 Sep 16. Mod Pathol. 2020. PMID: 31527709 Free PMC article.
-
Quantitative and pathologist-read comparison of the heterogeneity of programmed death-ligand 1 (PD-L1) expression in non-small cell lung cancer.Mod Pathol. 2017 Mar;30(3):340-349. doi: 10.1038/modpathol.2016.186. Epub 2016 Nov 11. Mod Pathol. 2017. PMID: 27834350 Free PMC article.
-
Programmed Death-Ligand 1 Immunohistochemistry Testing: A Review of Analytical Assays and Clinical Implementation in Non-Small-Cell Lung Cancer.J Clin Oncol. 2017 Dec 1;35(34):3867-3876. doi: 10.1200/JCO.2017.74.7642. Epub 2017 Oct 20. J Clin Oncol. 2017. PMID: 29053400 Review.
-
The Challenge to the Pathologist of PD-L1 Expression in Tumor Cells of Non-Small-Cell Lung Cancer-An Overview.Curr Oncol. 2021 Dec 8;28(6):5227-5239. doi: 10.3390/curroncol28060437. Curr Oncol. 2021. PMID: 34940076 Free PMC article. Review.
Cited by
-
Quantitative Image Analysis for Tissue Biomarker Use: A White Paper From the Digital Pathology Association.Appl Immunohistochem Mol Morphol. 2021 Aug 1;29(7):479-493. doi: 10.1097/PAI.0000000000000930. Appl Immunohistochem Mol Morphol. 2021. PMID: 33734106 Free PMC article.
-
Comparing deep learning and pathologist quantification of cell-level PD-L1 expression in non-small cell lung cancer whole-slide images.Sci Rep. 2024 Mar 26;14(1):7136. doi: 10.1038/s41598-024-57067-1. Sci Rep. 2024. PMID: 38531958 Free PMC article.
-
Development and applications of computer image analysis algorithms for scoring of PD-L1 immunohistochemistry.Immunooncol Technol. 2020 May 11;6:2-8. doi: 10.1016/j.iotech.2020.04.001. eCollection 2020 Jun. Immunooncol Technol. 2020. PMID: 35757235 Free PMC article. Review.
-
Digital Slide Assessment for Programmed Death-Ligand 1 Combined Positive Score in Head and Neck Squamous Carcinoma: Focus on Validation and Vision.Front Artif Intell. 2021 Jun 4;4:684034. doi: 10.3389/frai.2021.684034. eCollection 2021. Front Artif Intell. 2021. PMID: 34151256 Free PMC article. No abstract available.
-
Automated tumor proportion scoring for PD-L1 expression based on multistage ensemble strategy in non-small cell lung cancer.J Transl Med. 2021 Jun 7;19(1):249. doi: 10.1186/s12967-021-02898-z. J Transl Med. 2021. PMID: 34098964 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials